JoVE Logo
Faculty Resource Center

Sign In

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

DOI :

10.3791/54829-v

December 27th, 2016

December 27th, 2016

16,925 Views

1Pharmaceutical Design and Discovery (PharmDD), Faculty of Pharmacy, University of Helsinki

Biofilm infections show high tolerance towards chemotherapy. No single assay captures the complexity of biofilms. Instead, complementary assays are needed. We present a screening platform (developed for S. aureus) that combines assays for viability, biomass, and biofilm matrix. It allows anti-biofilm drug discovery, including the assessment of long-term chemotherapeutic effects.

Tags

Anti biofilm Assays

-- Views

Related Videos

article

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays

article

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

article

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials

article

Flow Cytometric Analysis of Natural Killer Cell Lytic Activity in Human Whole Blood

article

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

article

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli

article

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

article

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

article

Combining Analysis of DNA in a Crude Virion Extraction with the Analysis of RNA from Infected Leaves to Discover New Virus Genomes

article

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved